Berubicin
- Generic Name
- Berubicin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C34H35NO11
- CAS Number
- 677017-23-1
- Unique Ingredient Identifier
- 6QPN83HK2M
- Associated Conditions
- -
- Associated Therapies
- -
A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme
Phase 2
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-02-21
- Last Posted Date
- 2024-06-21
- Lead Sponsor
- CNS Pharmaceuticals, Inc.
- Target Recruit Count
- 210
- Registration Number
- NCT04762069
- Locations
- 🇺🇸
Baylor Research Institute, Dallas, Texas, United States
🇺🇸Southern California Permanente Medical Group, Los Angeles, California, United States
🇺🇸Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath